An Explorative, Multicenter, Open-Label Pilot Trial With Neupro (Rotigotine Transdermal Patch) Once Daily Treatment Administered Perioperatively in Patients With Idiopathic Parkinson's Disease.

Trial Profile

An Explorative, Multicenter, Open-Label Pilot Trial With Neupro (Rotigotine Transdermal Patch) Once Daily Treatment Administered Perioperatively in Patients With Idiopathic Parkinson's Disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Nov 2015

At a glance

  • Drugs Rotigotine (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms NEUPOS
  • Sponsors UCB
  • Most Recent Events

    • 08 Jul 2009 Actual end date changed from Oct 2008 to May 2008 as reported by ClinicalTrials.gov.
    • 21 Oct 2008 Actual patient number (14) added as reported by ClinicalTrials.gov.
    • 21 Oct 2008 Status changed from discontinued to completed as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top